CTOs on the Move


 
Headquartered in Redmond, Washington, WISErg is a privately held bio-clean technology company that converts food scraps from sources like grocery stores and restaurants into valuable, organic fertilizer. The company utilizes a patent-pending, oxidative conversion technology to intercept nutrients from food scraps before they become waste.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.wiserg.com
  • 15340 NE 92nd St Suite B
    Redmond, WA USA 98052
  • Phone: 800.592.2511

Executives

Name Title Contact Details

Funding

WISErg raised $19.2M on 01/03/2018

Similar Companies

Volcano Corporation

Volcano Corporation designs, develops, manufactures and commercializes a suite of intravascular ultrasound (IVUS) and functional measurement (FM) products that seeks to enhance the diagnosis and treatment of vascular and structural heart disease. The

Threshold Enterprises

Threshold Enterprises is a wholesale distributor of dietary supplements and health care products to the natural foods industry and health care professionals. We don't sell directly to consumers. If you want to open an account, or are a current customer

Integrated Genomics Inc

Integrated Genomics Inc is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lexaria Bioscience

Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. Lexaria has multiple patents pending and granted in over 40 countries around the world and was granted its first patent in the USA in October, 2016. Lexaria`s technology provides increases of up to 10x in intestinal absorption rates; more rapid delivery to the bloodstream with effects often within 15-20 minutes; and important taste-masking benefits, for orally administered bioactive molecules including but not limited to cannabinoids, vitamins, NSAIDs, and nicotine.

IgGenix

IgGenix is an early-stage, venture backed biotechnology company founded on breakthrough advances in Steve Quake`s laboratory at Stanford in collaboration with allergy clinician and researcher Kari Nadeau.